Abstract
Approximately 58,000 people in the USA will be diagnosed with kidney cancer in 2011, and an estimated 13,000 people will die as a result of the disease [1]. Cancer of the kidney represents 3.9 % of all U.S. cancers and 2 % of all cancer deaths. During their lifetime, 1 in 70 men and women will be diagnosed with cancer of the kidney or renal pelvis [2]. Worldwide, the mortality from renal cell carcinoma (RCC) is estimated to exceed 100,000 per year [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics 2010. CA Cancer J Clin. 2010;60(5):277–300.
Horner M, Ries L, Krapcho M, Neyman N, Aminou R. SEER cancer statistics review 1975–2006. Bethesda, MD 2009;(11):11.1–28. http://seer.cancer.gov/csr/1975_2006/. Accessed 1 Dec 2009.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr. Accessed 1 Dec 2009.
Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179(2):468–71 [discussion 72–3].
Mandel JS, McLaughlin JK, Schlehofer B, et al. International renal-cell cancer study. IV. Occupation. Int J Cancer. 1995;61(5):601–5.
La Vecchia C, Negri E, D’Avanzo B, Franceschi S. Smoking and renal cell carcinoma. Cancer Res. 1990;50(17):5231–3.
Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst. 1986;77(2):351–6.
Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114(1):101–8.
Brennan JF, Stilmant MM, Babayan RK, Siroky MB. Acquired renal cystic disease: implications for the urologist. Br J Urol. 1991;67(4):342–8.
Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Family history and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2001;10(9):1001–4.
Schlehofer B, Pommer W, Mellemgaard A, et al. International renal-cell-cancer study. VI. the role of medical and family history. Int J Cancer. 1996;66(6):723–6.
McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni Jr JF. A population–based case–control study of renal cell carcinoma. J Natl Cancer Inst. 1984;72(2):275–84.
Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Occupational risk factors for renal-cell carcinoma in Denmark. Scand J Work Environ Health. 1994;20(3):160–5.
Gnarra JR, Glenn GM, Latif F, et al. Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol Clin North Am. 1993;20(2):207–16.
Green FL, Blach CM, Haller DG, Morrow M. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
Edge SB, Byrd DR, Compton CA, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–30.
Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166(5):1611–23.
Jemal A, Siegel R, Ward E, Hao Y, Xu J. Cancer statistics 2009. CA Cancer J Clin. 2009;59:225–49.
Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008;113(1):78–83.
Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Fyfe G. High-dose aldesleukin in renal cell carcinoma: long-term survival update. Cancer J Sci Am. 1997;3 Suppl 1:S70–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Delacroix, S.E., Matin, S.F., Araujo, J., Wood, C.G. (2013). Kidney Cancer. In: Rodriguez, M., Walters, R., Burke, T. (eds) 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5197-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5197-6_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5196-9
Online ISBN: 978-1-4614-5197-6
eBook Packages: MedicineMedicine (R0)